- Home
- PED vs TIL Comparison
PED vs TIL Comparison
Compare PED & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- TIL
- Stock Information
- Founded
- PED N/A
- TIL 2018
- Country
- PED United States
- TIL United States
- Employees
- PED N/A
- TIL N/A
- Industry
- PED Oil & Gas Production
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- TIL Health Care
- Exchange
- PED Nasdaq
- TIL Nasdaq
- Market Cap
- PED 48.8M
- TIL 230.1M
- IPO Year
- PED N/A
- TIL 2021
- Fundamental
- Price
- PED $0.64
- TIL $28.30
- Analyst Decision
- PED Strong Buy
- TIL Buy
- Analyst Count
- PED 2
- TIL 5
- Target Price
- PED $1.63
- TIL $119.00
- AVG Volume (30 Days)
- PED 572.9K
- TIL 349.6K
- Earning Date
- PED 08-13-2025
- TIL 08-12-2025
- Dividend Yield
- PED N/A
- TIL N/A
- EPS Growth
- PED 2248.88
- TIL N/A
- EPS
- PED 0.19
- TIL N/A
- Revenue
- PED $40,173,000.00
- TIL N/A
- Revenue This Year
- PED N/A
- TIL N/A
- Revenue Next Year
- PED $5.99
- TIL N/A
- P/E Ratio
- PED $3.36
- TIL N/A
- Revenue Growth
- PED 30.70
- TIL N/A
- 52 Week Low
- PED $0.47
- TIL $9.62
- 52 Week High
- PED $1.10
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- PED 51.04
- TIL 46.80
- Support Level
- PED $0.63
- TIL $20.60
- Resistance Level
- PED $0.67
- TIL $25.95
- Average True Range (ATR)
- PED 0.05
- TIL 3.47
- MACD
- PED -0.01
- TIL -1.29
- Stochastic Oscillator
- PED 22.62
- TIL 22.74
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.